Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Stoke Therapeutics (STOK) Return on Assets (2022 - 2025)

Stoke Therapeutics has reported Return on Assets over the past 4 years, most recently at 0.0% for Q4 2025.

  • For Q4 2025, Return on Assets changed 0.0% year-over-year to 0.0%; the TTM value through Dec 2025 reached 0.0%, changed 0.0%, while the annual FY2025 figure was 0.0%, 0.0% changed from the prior year.
  • Return on Assets for Q4 2025 was 0.0% at Stoke Therapeutics, down from 0.0% in the prior quarter.
  • Over five years, Return on Assets peaked at 0.0% in Q1 2025 and troughed at 0.01% in Q1 2024.
  • A 4-year average of 0.0% and a median of 0.0% in 2023 define the central range for Return on Assets.
  • Biggest five-year swings in Return on Assets: changed 0bps in 2023 and later grew 1bps in 2025.
  • Year by year, Return on Assets stood at 0.0% in 2022, then decreased by -18bps to 0.0% in 2023, then increased by 30bps to 0.0% in 2024, then skyrocketed by 94bps to 0.0% in 2025.
  • Business Quant data shows Return on Assets for STOK at 0.0% in Q4 2025, 0.0% in Q3 2025, and 0.0% in Q2 2025.